Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 22639843)

1.

Long-term survival in patients with clear cell adenocarcinoma of ovary treated with irinotecan hydrochloride plus cisplatin therapy as first-line chemotherapy.

Kunito S, Takakura S, Nagata C, Saito M, Yanaihara N, Yamada K, Okamoto A, Sasaki H, Ochiai K, Tanaka T.

J Obstet Gynaecol Res. 2012 Dec;38(12):1367-75. doi: 10.1111/j.1447-0756.2012.01884.x. Epub 2012 May 28.

PMID:
22639843
2.

Adjuvant chemotherapy with irinotecan hydrochloride and cisplatin for clear cell carcinoma of the ovary.

Takano M, Kikuchi Y, Yaegashi N, Suzuki M, Tsuda H, Sagae S, Udagawa Y, Kuzuya K, Kigawa J, Takeuchi S, Tsuda H, Moriya T, Sugiyama T.

Oncol Rep. 2006 Dec;16(6):1301-6.

PMID:
17089053
3.

Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis.

Takano M, Sugiyama T, Yaegashi N, Suzuki M, Tsuda H, Sagae S, Udagawa Y, Kuzuya K, Kigawa J, Takeuchi S, Tsuda H, Moriya T, Kikuchi Y.

Int J Clin Oncol. 2007 Aug;12(4):256-60. Epub 2007 Aug 20.

PMID:
17701003
4.

Randomized phase II trial of paclitaxel plus carboplatin therapy versus irinotecan plus cisplatin therapy as first-line chemotherapy for clear cell adenocarcinoma of the ovary: a JGOG study.

Takakura S, Takano M, Takahashi F, Saito T, Aoki D, Inaba N, Noda K, Sugiyama T, Ochiai K; Japanese Gynecologic Oncology Group.

Int J Gynecol Cancer. 2010 Feb;20(2):240-7.

PMID:
20169667
5.

Adjuvant chemotherapy for stage I clear cell carcinoma of the ovary: an analysis of fully staged patients.

Takada T, Iwase H, Iitsuka C, Nomura H, Sakamoto K, Omatsu K, Takeshima N, Takizawa K.

Int J Gynecol Cancer. 2012 May;22(4):573-8. doi: 10.1097/IGC.0b013e31823fd413.

PMID:
22398705
6.

Irinotecan hydrochloride (CPT-11) and cisplatin as first-line chemotherapy after initial surgery for ovarian clear cell adenocarcinoma.

Takakura S, Saito M, Ueda K, Motegi M, Takao M, Yamada K, Okamoto A, Niimi S, Sasaki H, Tanaka T, Ochiai K.

Int Surg. 2007 Jul-Aug;92(4):202-8.

PMID:
18050828
7.

Irinotecan hydrochloride (CPT-11) and mitomycin C as the first line chemotherapy for ovarian clear cell adenocarcinoma.

Nishino K, Aoki Y, Amikura T, Obata H, Sekine M, Yahata T, Fujita K, Tanaka K.

Gynecol Oncol. 2005 Jun;97(3):893-7.

PMID:
15894369
8.

Exploratory study of effective chemotherapy to clear cell carcinoma of the ovary.

Kita T, Kikuchi Y, Kudoh K, Takano M, Goto T, Hirata J, Tode T, Nagata I.

Oncol Rep. 2000 Mar-Apr;7(2):327-31.

PMID:
10671681
9.

Survival impact of adjuvant paclitaxel and carboplatin for early-stage ovarian clear-cell carcinoma with complete surgical staging.

Kajiyama H, Shibata K, Suzuki S, Ino K, Kawai M, Nagasaka T, Nawa A, Kikkawa F.

Gynecol Obstet Invest. 2011;72(4):252-6. doi: 10.1159/000327924. Epub 2011 Oct 25.

PMID:
22041903
10.

Low response rate of second-line chemotherapy for recurrent or refractory clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study.

Takano M, Sugiyama T, Yaegashi N, Sakuma M, Suzuki M, Saga Y, Kuzuya K, Kigawa J, Shimada M, Tsuda H, Moriya T, Yoshizaki A, Kita T, Kikuchi Y.

Int J Gynecol Cancer. 2008 Sep-Oct;18(5):937-42. Epub 2007 Dec 13.

PMID:
18081792
11.

A phase II study of combination chemotherapy using docetaxel and irinotecan for TC-refractory or TC-resistant ovarian carcinomas (GOGO-OV2 study) and for primary clear or mucinous ovarian carcinomas (GOGO-OV3 Study).

Ueda Y, Miyatake T, Nagamatsu M, Yamasaki M, Nishio Y, Yoshino K, Fujita M, Tsutsui T, Enomoto T, Kimura T.

Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):259-63. doi: 10.1016/j.ejogrb.2013.06.035. Epub 2013 Jul 20.

PMID:
23880598
12.

Survival impact of capsule rupture in stage I clear cell carcinoma of the ovary in comparison with other histological types.

Higashi M, Kajiyama H, Shibata K, Mizuno M, Mizuno K, Hosono S, Kawai M, Nakanishi T, Nagasaka T, Kikkawa F.

Gynecol Oncol. 2011 Dec;123(3):474-8. doi: 10.1016/j.ygyno.2011.08.036. Epub 2011 Sep 28.

PMID:
21955484
13.

[A case of brain metastasis from advanced ovarian clear-cell carcinoma during maintenance chemotherapy with irinotecan+cisplatin].

Takami M, Kita E, Kuwana Y, Ohta Y, Nakayama Y, Fukai H, Matsumoto H, Takimoto T, Ichikawa G, Yamamoto T.

Gan To Kagaku Ryoho. 2008 Jul;35(7):1243-5. Japanese.

PMID:
18633273
14.

Salvage chemotherapy for recurrent or persistent clear cell carcinoma of the ovary: a single-institution experience for a series of 20 patients.

Yoshino K, Enomoto T, Fujita M, Ueda Y, Kimura T, Kobayashi E, Tsutsui T, Kimura T.

Int J Clin Oncol. 2013 Feb;18(1):148-53. doi: 10.1007/s10147-011-0357-5. Epub 2011 Dec 10.

PMID:
22160560
15.

[Prognostic analysis of 88 patients with ovarian clear cell carcinoma].

Ma SK, Zhang HT, Wu LY, Liu LY.

Zhonghua Zhong Liu Za Zhi. 2007 Oct;29(10):784-8. Chinese.

PMID:
18396695
16.

Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.

Pectasides D, Fountzilas G, Aravantinos G, Kalofonos C, Efstathiou H, Farmakis D, Skarlos D, Pavlidis N, Economopoulos T, Dimopoulos MA.

Gynecol Oncol. 2006 Aug;102(2):285-91. Epub 2006 Mar 3.

PMID:
16516283
17.

Adjuvant chemotherapy for stage i ovarian clear cell carcinoma: is it necessary for stage IA?

Mizuno M, Kajiyama H, Shibata K, Mizuno K, Yamamuro O, Kawai M, Nakanishi T, Nagasaka T, Kikkawa F.

Int J Gynecol Cancer. 2012 Sep;22(7):1143-9. doi: 10.1097/IGC.0b013e31825c7cbe.

PMID:
22801028
18.

Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging.

Takano M, Kikuchi Y, Yaegashi N, Kuzuya K, Ueki M, Tsuda H, Suzuki M, Kigawa J, Takeuchi S, Tsuda H, Moriya T, Sugiyama T.

Br J Cancer. 2006 May 22;94(10):1369-74.

19.

A phase II study of combined CPT-11 and mitomycin-C in platinum refractory clear cell and mucinous ovarian carcinoma.

Shimizu Y, Umezawa S, Hasumi K.

Ann Acad Med Singapore. 1998 Sep;27(5):650-6.

PMID:
9919334
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk